window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 9, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

colorectal cancer

  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Genomics and sequencing,Therapeutic Areas

    Primerdesign and Origin partner on rectal mucus DNA extraction for colorectal cancer detection

    Primerdesign and Origin Sciences partner to develop a DNA extraction [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Therapeutic Areas

    Promatix shows 50-fold potency in colorectal cancer with PBS293 ADC

    Promatix Biosciences has reported preclinical data showing its cis-bispecific ADC [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Bicara announces Phase 3 optimal dose for ficerafusp alfa and provides 2026 corporate outlook

    Bicara Therapeutics has selected 1500 mg of ficerafusp alfa as [...]

    May 5, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    MediciNova completes patient enrollment in Phase 2 neuropathy prevention study

    MediciNova has completed patient enrollment in a Phase 2 clinical [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Inaphaea BioLabs boosts precision oncology with new partnerships, advanced tumour models, and digital patient avatars

    Inaphaea BioLabs, the translational contract research organisation (CRO) of ValiRx [...]

    May 5, 2026
  • Clinical & Regulatory,Medical devices,Opinion & Events,Therapeutic Areas

    Refold AI emerges to simplify enterprise integrations with agentic platform

    Mainz Biomed N.V., a molecular genetics diagnostic company specializing in [...]

    May 5, 2026
  • Therapeutic Areas

    Tagomics secures £860k Innovate UK grant to advance early detection of colorectal cancer

    Project aims to apply multiomic profiling for non-invasive diagnostic development [...]

    May 5, 2026
  • Drug Discovery & Development

    SOTIO’s SOT109 targets CDH17 in colorectal cancer: A new ADC contender emerges

    SOTIO’s lead candidate, SOT109, is generating buzz in the ADC [...]

    May 5, 2026
  • Biotech & Pharma Business

    Mainz Biomed and EDX Medical Group form technology partnership to expand access to molecular cancer diagnostics in the UK

    Mainz Biomed, a molecular diagnostics company focused on the early [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Trelleborg gains ISO certification for Costa Rica medtech plant
    Categories: Clinical & Regulatory, Manufacturing & Supply Chain, Medical devices
  • Merck launches bio-based HPLC solvents for pharma labs
    Categories: Drug Discovery & Development, Manufacturing & Supply Chain
  • Alto starts Phase 2b ALTO-207 trial in treatment-resistant depression
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top